Sinopharm
1099.HK
#2290
Rank
โ‚น718.56 B
Marketcap
โ‚น230.26
Share price
0.30%
Change (1 day)
2.29%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2024: โ‚น206.96 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น80.09 Billion. In 2024 the company made an earning of โ‚น206.96 Billion a decrease over its 2023 earnings that were of โ‚น286.89 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2024

Annual earnings

Year Earnings Change
2024โ‚น206.96 B-27.86%
2023โ‚น286.89 B-0.73%
2022โ‚น289.00 B-1.72%
2021โ‚น294.04 B11.7%
2020โ‚น263.24 B18.44%
2019โ‚น222.25 B10.85%
2018โ‚น200.50 B3.05%
2017โ‚น194.57 B36.48%
2016โ‚น142.56 B7.11%
2015โ‚น133.10 B12.38%
2014โ‚น118.44 B25.05%
2013โ‚น94.72 B22.54%
2012โ‚น77.29 B35.43%
2011โ‚น57.07 B52.24%
2010โ‚น37.48 B30.99%
2009โ‚น28.62 B60.59%
2008โ‚น17.82 B48.29%
2007โ‚น12.01 B123.29%
2006โ‚น5.38 B